Editorial: Immunologic Approaches to the Treatment of Cancer
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 13 (3) , 339-340
- https://doi.org/10.3109/07357909509094469
Abstract
(1995). Editorial: Immunologic Approaches to the Treatment of Cancer. Cancer Investigation: Vol. 13, No. 3, pp. 339-340. doi: 10.3109/07357909509094469This publication has 8 references indexed in Scilit:
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.Proceedings of the National Academy of Sciences, 1994
- In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.Journal of Clinical Oncology, 1994
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2JAMA, 1994
- Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2Cancer Immunology, Immunotherapy, 1993
- Human Renal Carcinoma Line Transfected With Interleukin-2 and/or Interferon Gene(s): Implications for Live Cancer VaccinesJNCI Journal of the National Cancer Institute, 1993